论文部分内容阅读
[目的]探讨氩离子凝固术在早期食管癌及癌前病变的临床应用价值。[方法]选择某院收治的98例早期食管癌及癌前患者,选择56例患者为观察组,使用氩离子凝固术进行治疗,记录术中及术后并发症,选择42例患者为对照组,给予常规治疗,所有患者术后1年复查胃镜,对比其治疗效果。[结果]观察组治愈率明显高于对照组(P﹤0.01),无效及加重的比率明显低于对照组(P﹤0.01);观察组术中3例创面出血,术后出血1例,均在内镜下成功止血;39例术后发生不同程度的胸痛,3～6d后自行好转;1例出现黑便,1d之后正常。[结论]使用氩离子凝固术治疗早期食管癌及癌前病变手术成功率较高,并发症较少。
[Objective] To investigate the clinical value of argon ion coagulation in early esophageal cancer and precancerous lesions. [Method] Select 98 cases of early esophageal cancer and precancerous patients admitted to a hospital, select 56 patients as observation group, the use of argon ion coagulation therapy, recording intraoperative and postoperative complications, 42 patients were selected as the control group , Given conventional treatment, all patients 1 year after endoscopy, compared with its therapeutic effect. [Results] The cure rate of the observation group was significantly higher than that of the control group (P <0.01), and the rate of ineffectiveness and aggravation was significantly lower than that of the control group (P <0.01). In the observation group, 3 cases of intraoperative bleeding and 1 case of postoperative bleeding Thirty-nine patients had different degrees of postoperative chest pain, 3 to 6 days after their own improvement; 1 case of melena, 1d after normal. [Conclusion] The success rate of argon ion coagulation in the treatment of early esophageal cancer and precancerous lesions is high, with fewer complications.